首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1424175

精準診斷與檢測技術進步

Technology Advancements in Precision Diagnostics and Testing

出版日期: 2023年12月21日 | 出版商:

Frost & Sullivan | 英文 78 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

創新正在推動價值醫學時代的到來，並實現預防性和個人化醫學。

精確的診斷在當今的醫療保健中至關重要，可以根據遺傳、分子和環境因素為個別患者量身定做治療方案。這種有針對性的方法提高了準確性，實現了早期檢測和有針對性的治療，最大限度地減少了試驗錯治療，並最佳化了治療結果。

透過利用先進技術和個人化資料，精準診斷使醫療保健專業人員能夠做出明智的決策，改善患者照護，並提供更有效和高效的醫療保健。促進護理服務。

尖端的精準診斷技術正在改變醫學和患者照護的模式。這些先進技術細緻地分析血液、組織和遺傳物質等生物樣本，以準確診斷各種疾病和病症。精準診斷技術在醫療保健中的重要性在於其能夠準確識別疾病、減少誤診、防止不必要的治療、提高標靶治療的有效性。最終，這有助於改善患者的治療效果。

基因組定序、突變組學以及人工智慧和巨量資料整合的技術進步正在推動該領域的成長。

Frost & Sullivan 的這項研究服務專注於識別各種能夠實現精準診斷的新興技術、研究各種技術的關鍵參與者以及精準診斷在各種疾病領域的適用性。

Frost & Sullivan 確定了精準診斷領域的三個成長機會，這些機會有可能改變市場。

主要問題

1.精準診斷和測試開發的促進因素和挑戰是什麼？

2. 精準診斷將如何改變各疾病領域的診斷？

3. 粒線體療法的資金籌措和合作方案是什麼？

4. 精準診斷和檢測領域的主要創新者有哪些？

5.該領域的研究和發展趨勢是什麼？

6.主要的成長機會是什麼？

介紹
促進因素
促進因素分析
成長抑制因素
成長抑制因素分析
範圍和細分
精確診斷的效用
液體活體組織切片精準診斷
預測性基因檢測作為詳細檢查的有效手段
藥物基因體學在精準診斷的應用
PCR技術的進步
新技術強化精密檢測
實現詳細檢查/診斷的新技術

精準診斷：應用於多種疾病

詳細檢查在癌症領域的作用
實現腫瘤學詳細檢查/診斷的技術
實現精準醫療的新型生物標記
實現精準醫療的微流控設備
創新聚焦－癌症領域精準偵測技術
最近的伴隨診斷核准- 癌症治療選擇
感染疾病－需要詳細檢查
透過詳細測試實現感染疾病監測和管理
感染疾病詳細檢查新技術
可對感染疾病進行詳細檢查/診斷的分子診斷劑
多重分子 POC 測試可實現精準醫療
創新聚焦－感染疾病精準檢測技術
神經系統疾病 - 診斷挑戰
精密測試如何克服當前的診斷挑戰
基於血液的生物標記可改善神經退化性疾病評估
能夠對神經系統疾病進行詳細檢查/診斷的技術
創新聚焦－神經系統疾病詳細檢查技術
CVD-當前檢查問題和未來方向
可對 CVD 進行詳細檢查/診斷的分子診斷
創新聚焦－神經系統疾病詳細檢查技術
遺傳/罕見疾病 - 診斷挑戰
精確的測試方法可克服遺傳/罕見疾病的診斷挑戰
可對遺傳/罕見疾病進行詳細檢查/診斷的技術

實現精確診斷的因素

實現精準診斷
精密檢測中的人工智慧和機器學習
應用
巨量資料分析細化檢驗

研發重點

加強細節檢查的策略性問題

市場動態

公共和私人資金推動精確測試開發
與精準診斷公司合作

成長機會宇宙

成長機會 1：擴大基因組篩檢的採用
成長機會2：加強巨量資料和人工智慧
成長機會3：新生物標記的發現

下一步

下一步
為什麼是霜凍，為什麼是現在？
免責聲明

簡介目錄

Product Code: DACA

Innovation is driving the era of value-based care and enabling preventive and personalized health.

Precision diagnosis in today's healthcare is pivotal, tailoring treatment to individual patients based on genetic, molecular, and environmental factors. This targeted approach enhances accuracy, enables early detection and targeted treatment, minimizes trial-and-error treatment, and optimizes therapeutic outcomes.

By leveraging advanced technologies and personalized data, precision diagnosis empowers healthcare professionals to make informed decisions, improving patient care and fostering more effective and efficient healthcare delivery.

Cutting-edge precision diagnostic technologies are transforming the medical science and patient care landscape. These advanced methods meticulously analyze biological samples, such as blood, tissue, and genetic material, to accurately diagnose a range of diseases and conditions. The importance of precision diagnostic technology in healthcare lies in its ability to precisely identify diseases, reduce misdiagnoses, prevent unnecessary treatment, and enhance the effectiveness of targeted therapies. Ultimately, this contributes to improved patient outcomes.

Technology advancements around genomic sequencing, muti-omics, and AI and Big Data integration have boosted this space's growth.

This Frost & Sullivan research service focuses on identifying different emerging technologies that enable precision diagnosis, key participants working on different technologies, and the applicability of precision diagnosis across different disease areas.

Frost & Sullivan identifies 3 growth opportunities for precision diagnosis that could potentially transform the market.

Key Questions Answered

1. What are the drivers and challenges for precision diagnostics and testing development?

2. How can precision diagnosis transform diagnosis across different disease areas?

3. What does the mitochondrial therapeutics funding and partnership scenario look like?

4. Who are the main precision diagnostics and testing innovators?

5. What are the R&D trends in this space?

6. What are the key growth opportunities?

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Precision Diagnostics and Testing
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Growth Opportunity Analysis

Introduction
Growth Drivers
Growth Driver Analysis
Growth Restraints
Growth Restraint Analysis
Scope and Segmentation
Utility of Precision Diagnostics
Liquid Biopsy in Precision Diagnosis
Predictive Genetic Testing as an Effective Tool for Precision Testing
Pharmacogenomics in Precision Diagnosis
Technological Advancements in PCR)
Emerging Technologies Bolstering Precision Testing
Emerging Technologies Enabling Precision Testing/Diagnosis

Precision Diagnostics: Application across Different Diseases

The Role of Precision Testing in Oncology
Technologies Enabling Precision Testing/Diagnosis for Oncology
Novel Biomarkers Enabling Precision Medicine
Microfluidic Devices Enabling Precision Medicine
Innovation Spotlight-Precision Testing Technology for Oncology
Recent CDx Approvals-Cancer Therapy Selection
Infectious Diseases-The Need for Precision Testing
Precision Testing Enables Infectious Disease Surveillance and Management
Emerging Technologies for the Precision Testing of Infectious Diseases
Molecular Diagnostics Enabling Precision Testing/Diagnosis for Infectious Diseases
Multiplex Molecular POC Testing Enabling Precision Medicine
Innovation Spotlight-Precision Testing Technology for Infectious Diseases
Neurological Diseases-Challenges with Diagnostics
How Precision Testing Helps Overcome Current Diagnostic Challenges
Blood-based Biomarkers to Improve Neurodegenerative Disease Assessment
Technologies Enabling Precision Testing/Diagnosis for Neurological Diseases
Innovation Spotlight-Precision Testing Technology for Neurological Diseases
CVDs-Current Testing Challenges and the Way Forward
Molecular Diagnostics Enabling Precision Testing/Diagnosis for CVDs
Innovation Spotlight-Precision Testing Technology for Neurological Diseases
Genetic/Rare Diseases-Challenges With Diagnosis
How Precision Testing Helps Overcome Current Diagnostic Challenges in Genetic/Rare Diseases
Technologies Enabling Precision Testing/Diagnosis for Genetic/Rare Diseases